Dr. Janette Iking currently is a postdoctoral researcher in the field of preclinical imaging and translational oncology at the Dept. of Nuclear Medicine of the University Hospital Essen, Germany, studying radioligand combination therapies for prostate cancer. She was awarded her PhD from the University of Münster, Germany, for developing a preclinical imaging setup to study post-infarct human monocyte migration for which she won several awards at national and international conferences. Dr. Iking attended the University of Göttingen, Germany, and the University of Manchester, UK, for her undergraduate studies in biological sciences. Her research interests include developing methods to visualize the immune system in cancer and cardiovascular diseases in order to gain new insight into disease progression and novel therapeutic strategies.
Dr. Janette Iking currently is a postdoctoral researcher in the field of preclinical imaging and translational oncology at the Dept. of Nuclear Medicine of the University Hospital Essen, Germany, studying radioligand combination therapies for prostate cancer. She was awarded her PhD from the University of Münster, Germany, for developing a preclinical imaging setup to study post-infarct human monocyte migration for which she won several awards at national and international conferences. Dr. Iking attended the University of Göttingen, Germany, and the University of Manchester, UK, for her undergraduate studies in biological sciences. Her research interests include developing methods to visualize the immune system in cancer and cardiovascular diseases in order to gain new insight into disease progression and novel therapeutic strategies.